Your browser doesn't support javascript.
loading
ETA receptor blockade with atrasentan prevents hypertension with the multitargeted tyrosine kinase inhibitor ABT-869 in telemetry-instrumented rats.
Banfor, Patricia N; Franklin, Pamela A; Segreti, Jason A; Widomski, Deborah L; Davidsen, Steven K; Albert, Daniel H; Cox, Bryan F; Fryer, Ryan M; Gintant, Gary A.
Affiliation
  • Banfor PN; Department of Integrative Pharmacology, Global Pharmaceutical Research and Development, Abbott Laboratories, Abbott Park, IL 60064-6119, USA. patricia.banfor@abbott.com
J Cardiovasc Pharmacol ; 53(2): 173-8, 2009 Feb.
Article in En | MEDLINE | ID: mdl-19188829
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyrrolidines / Receptor Protein-Tyrosine Kinases / Angiogenesis Inhibitors / Endothelin A Receptor Antagonists / Hypertension / Indazoles Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Cardiovasc Pharmacol Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenylurea Compounds / Pyrrolidines / Receptor Protein-Tyrosine Kinases / Angiogenesis Inhibitors / Endothelin A Receptor Antagonists / Hypertension / Indazoles Type of study: Prognostic_studies Limits: Animals Language: En Journal: J Cardiovasc Pharmacol Year: 2009 Document type: Article Affiliation country: United States Country of publication: United States